Table S2.
Bacterial pathogens identified in specimen samples, including multidrug-resistant organisms, overall and by country
| Bacterial pathogena | Brazil (n=67)b | France (n=65) | Italy (n=68) | Russia (n=74) | Spain (n=89) | Total (N=363)b |
|---|---|---|---|---|---|---|
| n | 64 | 48 | 44 | 43 | 71 | 270 |
| Gram-negative, n (%)c | 50 (78.1) | 35 (72.9) | 34 (77.3) | 39 (90.7) | 63 (88.7) | 221 (81.9) |
| Escherichia coli | 31 (48.4) | 21 (43.8) | 19 (43.2) | 17 (39.5) | 39 (54.9) | 127 (47.0) |
| Klebsiella spp. | 11 (17.2) | 3 (6.3) | 6 (13.6) | 17 (39.5) | 9 (12.7) | 46 (17.0) |
| Pseudomonas aeruginosa | 4 (6.3) | 5 (10.4) | 3 (6.8) | 1 (2.3) | 17 (23.9) | 30 (11.1) |
| Enterobacter spp. | 7 (10.9) | 3 (6.3) | 8 (18.2) | 0 (0.0) | 5 (7.0) | 23 (8.5) |
| Acinetobacter spp. | 4 (6.3) | 0 (0.0) | 1 (2.3) | 6 (14.0) | 3 (4.2) | 14 (5.2) |
| Proteus spp. | 1 (1.6) | 1 (2.1) | 0 (0.0) | 1 (2.3) | 4 (5.6) | 7 (2.6) |
| Citrobacter spp. | 0 (0.0) | 1 (2.1) | 1 (2.3) | 0 (0.0) | 2 (2.8) | 4 (1.5) |
| Serratia spp. | 0 (0.0) | 1 (2.1) | 0 (0.0) | 2 (4.7) | 1 (1.4) | 4 (1.5) |
| Morganella morganii | 1 (1.6) | 1 (2.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.7) |
| Haemophilus spp. | 0 (0.0) | 1 (2.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.4) |
| Salmonella spp. | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.4) | 1 (0.4) |
| Other | 1 (1.6) | 2 (4.2) | 2 (4.5) | 0 (0.0) | 7 (9.9) | 12 (4.4) |
| Gram-positive, n (%)c | 20 (31.3) | 19 (39.6) | 18 (40.9) | 6 (14.0) | 29 (40.8) | 92 (34.1) |
| Enterococcus spp. | 8 (12.5) | 15 (31.3) | 8 (18.2) | 5 (11.6) | 18 (25.4) | 54 (20.0) |
| Staphylococcus spp. | 11 (17.2) | 4 (8.3) | 7 (15.9) | 0 (0.0) | 7 (9.9) | 29 (10.7) |
| Streptococcus spp. | 2 (3.1) | 2 (4.2) | 4 (9.1) | 1 (2.3) | 7 (9.9) | 16 (5.9) |
| Other | 0 (0.0) | 1 (2.1) | 0 (0.0) | 0 (0.0) | 1 (1.4) | 2 (0.7) |
| Anaerobic bacteria, n (%)c | 0 (0.0) | 9 (18.8) | 2 (4.5) | 0 (0.0) | 10 (14.1) | 21 (7.8) |
| Bacteroides spp. | 0 (0.0) | 6 (12.5) | 2 (4.5) | 0 (0.0) | 7 (9.9) | 15 (5.6) |
| Clostridium spp. | 0 (0.0) | 2 (4.2) | 0 (0.0) | 0 (0.0) | 2 (2.8) | 4 (1.5) |
| Prevotella spp. | 0 (0.0) | 1 (2.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.4) |
| Other | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.4) | 1 (0.4) |
| Other bacterial agent, n (%)c | 1 (1.6) | 2 (4.2) | 0 (0.0) | 0 (0.0) | 3 (4.2) | 6 (2.2) |
| Multidrug-resistant pathogen, n (%)c | ||||||
| Yes | 20 (31.3) | 23 (47.9) | 14 (31.8) | 22 (51.2) | 33 (46.5) | 112 (41.5) |
| No | 44 (68.8) | 25 (52.1) | 30 (68.2) | 21 (48.8) | 38 (53.5) | 158 (58.5) |
| Missing | 25 | 17 | 24 | 31 | 18 | 115 |
| Fungal pathogen, n (%)d | 2 (3.0) | 8 (12.3) | 5 (7.4) | 0 (0.0) | 15 (16.9) | 30 (8.3) |
Notes:
a
Patients could have more than one pathogen type identified.
b
Data missing for 22 patients in Brazil.
c
Percentages are calculated as a proportion of those patients with ≥1 bacterial pathogen identified.
d
Percentages are calculated as a proportion of the overall population.